January 13, 2020 12:34 PM EST

PACT Pharma bags $75M for neoantigen TCR work, manufacturing; Bayer grabs experimental contraceptive from Daré

→ With a new president and chief technical officer in place, next-gen T cell therapy player PACT Pharma has $75 million …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

PACT Phar­ma bags $75M for neoanti­gen TCR work, man­u­fac­tur­ing; Bay­er grabs ex­per­i­men­tal con­tra­cep­tive from Daré